Sign in
4

Changes in Ownership

Axogen, Inc. Filed Acc 0000805928-24-000049

Chief Innovation Officer sold 4,578 shares at $7.68 ($35,159)

  • Chief Innovation Officer acquired 18,675 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

DeVinney Erick Wayne · Chief Innovation Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2024-03-16 Exercise or conversion : show line 1 in the form +3,000 166,377 D
2024-03-21 Sale : show line 2 in the form −716 $7.68 $5,499 165,661 D
2024-03-16 Exercise or conversion : show line 3 in the form +2,950 168,611 D
2024-03-21 Sale : show line 4 in the form −721 $7.68 $5,537 167,890 D
2024-03-16 Exercise or conversion : show line 5 in the form +12,725 180,615 D
2024-03-21 Sale : show line 6 in the form −3,141 $7.68 $24,123 177,474 D
Open-market sales · 4,578 sh · avg $7.68 · $35,159

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2024-03-16 Exercise or conversion : show line 7 in the form Restricted Stock Units −3,000 0 D
2024-03-16 Exercise or conversion : show line 8 in the form Restricted Stock Units −2,950 2,950 D
2024-03-16 Exercise or conversion : show line 9 in the form Restricted Stock Units −12,725 12,725 D
Loading xslF345X05/wk-form4_1711417219.xml…